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Abstract
Background: In shotgun metagenomics, microbial communities are studied through direct sequencing of DNA
without any prior cultivation. By comparing gene abundances estimated from the generated sequencing reads,
functional differences between the communities can be identified. However, gene abundance data is affected by
high levels of systematic variability, which can greatly reduce the statistical power and introduce false positives.
Normalization, which is the process where systematic variability is identified and removed, is therefore a vital part of
the data analysis. A wide range of normalization methods for high-dimensional count data has been proposed but
their performance on the analysis of shotgun metagenomic data has not been evaluated.
Results: Here, we present a systematic evaluation of nine normalization methods for gene abundance data. The
methods were evaluated through resampling of three comprehensive datasets, creating a realistic setting that
preserved the unique characteristics of metagenomic data. Performance was measured in terms of the methods ability
to identify differentially abundant genes (DAGs), correctly calculate unbiased p-values and control the false discovery
rate (FDR). Our results showed that the choice of normalization method has a large impact on the end results. When
the DAGs were asymmetrically present between the experimental conditions, many normalization methods had a
reduced true positive rate (TPR) and a high false positive rate (FPR). The methods trimmed mean of M-values (TMM)
and relative log expression (RLE) had the overall highest performance and are therefore recommended for the analysis
of gene abundance data. For larger sample sizes, CSS also showed satisfactory performance.
Conclusions: This study emphasizes the importance of selecting a suitable normalization methods in the analysis of
data from shotgun metagenomics. Our results also demonstrate that improper methods may result in unacceptably
high levels of false positives, which in turn may lead to incorrect or obfuscated biological interpretation.
Keywords: Shotgun metagenomics, Gene abundances, Normalization, High-dimensional data, Systematic variability,
False discovery rate
Background
In shotgun metagenomics, microorganisms are studied by
sequencing DNA fragments directly from samples with-
out the need for cultivation of individual isolates [1]. Since
shotgun metagenomics is culture-independent, it pro-
vides an efficient and unbiased way to describe microbial
communities, their taxonomic structure and biochemi-
cal potential [2]. The increasing performance of high-
throughput DNA sequencing technologies has rapidly
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expanded the potential of metagenomics, making it a
key measurement technique in the analysis of the human
microbiome and environmental microbial communities
[3–6]. The data produced by shotgun metagenomics is
often analyzed based on the presence of genes and their
abundances in and between samples from different exper-
imental conditions. The gene abundances are estimated
by matching each generated sequence read against a com-
prehensive and annotated reference database [7–9]. The
database typically consists of previously characterized
microbial genomes, a catalog of genes or de novo assem-
bled contiguous sequences. The gene abundances are then
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calculated by counting the number of readsmatching each
gene in the reference database. Finally, statistical analy-
sis is used to identify the genes that have a significant
differential abundance between the studied conditions.
Gene abundance data generated by shotgun metage-
nomics is however affected with multiple sources of
variability which makes it notoriously hard to interpret
[10–12]. A substantial part of this variability is system-
atic and affects multiple genes and/or samples in a similar
way. One example of systematic variability is the differ-
ences in sequence depth, where each sample is repre-
sented by a varying number of reads [13]. Systematic
variability also comes from other technical sources, such
as inconsistencies in the DNA extraction and sample han-
dling, varying quality between sequencing runs, errors
in the read mapping, and incompleteness of the refer-
ence databases [14]. In addition, systematic variabilitymay
also be of biological nature, where, for example, sample-
specific differences in average genome size, species rich-
ness and GC-content of the reads can affect the gene
abundance [15, 16]. Regardless of its source, systematic
variability significantly increases the variation between
samples and thereby decrease the ability to identify genes
that differ in abundance. Removal of systematic variabil-
ity, a process referred to as normalization, is therefore
vital to achieve a satisfactory statistical power and an
acceptable FPR.
A wide range of different methods has been applied to
normalize shotgun metagenomic data. The majority of
these normalization methods are based on scaling, where
a sample-specific factor is estimated and then used to cor-
rect the gene abundances. One approach is to derive the
scaling factor from the total gene counts present in the
sample [17, 18]. This enables removal of the often substan-
tial differences in sequencing depth. However, the total
gene counts is heavily dominated by the most abundant
genes such that their variability may have a major impact
on the scaling factor. To avoid the variability caused by
high-abundant genes, the median and upper quartile nor-
malization methods have been proposed as more robust
alternatives [12, 19]. These methods estimate the scaling
factors based on the 50th and 75th percentile of the gene
count distribution, respectively. Similarly, the normaliza-
tion method cumulative sum scaling (CSS) calculates the
scaling factors as a sum of gene counts up to a threshold
[20]. Themethod optimizes the threshold from the data in
order to minimize the influence of variable high-abundant
genes. Another method that robustly estimates the scaling
factor is the TMM [21], which compares the gene abun-
dances in the samples against a reference, typically set
as one of the samples in the study. The scaling factor is
then derived using a weighted trimmedmean over the dif-
ferences of the log-transformed gene-count fold-change
between the sample and the reference. Similarly to TMM,
relative log expression (RLE) calculates scaling factors
by comparing the samples to a reference [22]. However,
in contrast to TMM, RLE uses a pseudo-reference cal-
culated using the geometric mean of the gene-specific
abundances over all samples in the study. The scaling fac-
tors are then calculated as the median of the gene counts
ratios between the samples and the reference. A com-
monly used normalization method that is not based on
scaling is rarefying, where reads in the different samples
are randomly removed until the same predefined number
has been reached, thereby assuring a uniform sequence
depth [13, 23]. Another method that avoids scaling is
the quantile-quantile normalization, in which the gene
abundance distributions in different samples are made
identical by adjusting their quantiles according to a refer-
ence distribution derived by averaging over all the samples
[19, 24, 25].
Comparisons of normalizationmethods have previously
been done for RNA-seq data [19, 26] as well as count data
produced from the study of operational taxonomic units
(OTUs) generated by amplicon sequencing [13, 23]. These
studies found a large dependency between performance
and data characteristics. Thus, it is likely that normaliza-
tion methods that have previously been shown to perform
well for other forms of count data are not appropriate
for shotgun metagenomics. Indeed, metagenomic gene
abundance data is almost always highly undersampled and
plagued by high technical noise and biological between-
sample variability, which makes it dependent on proper
normalization [12]. However, no evaluation of data-driven
normalization methods for shotgun metagenomics has
been performed. It is therefore unclear how the normal-
ization should be performed to ensure a correct interpre-
tation of the end results.
To address this knowledge gap and to provide guidance
in choosing a suitable data-driven normalization method,
we have performed a systematic evaluation of nine meth-
ods on gene abundance data from shotgunmetagenomics.
The evaluation was performed on datasets formed by
individual resampling of three comprehensive metage-
nomic datasets, thereby creating a realistic setting where
the unique characteristics and variance structure of the
data are preserved. The methods were evaluated based on
their impact on the identification of DAGs by comparing
their TPR and FPR as well as their ability to correctly esti-
mate unbiased p-values and control the FDR. Our results
showed that the normalization methods had a substan-
tially different performance in identifying DAGs. Several
of the methods demonstrated a high FPR, especially when
the DAGs were distributed asymmetrically between the
experimental conditions. In some cases, the high FPR also
resulted in an unacceptably high FDR. TMM and RLE had
the overall highest performance, with a high TPR, low
FPR and a low FDR in most of the evaluated scenarios
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and are therefore recommended methods for normaliza-
tion of gene abundance data. We conclude that the choice
of normalization method is critical in shotgun metage-
nomics and may, if not done correctly, result in incorrect
biological interpretations.
Methods
Normalization methods
In this study we evaluate the performance of nine nor-
malization methods for count data, representing gene
abundances from shotgun metagenomics (Table 1). Seven
methods were scaling methods, where a sample-specific
normalization factor is calculated and used to correct the
counts, while two methods operate by replacing the non-
normalized data with new normalized counts. Assume
that gene abundance data is given as counts describing the
number of DNA fragments sampled for each gene from a
microbial community. Let Yij be the counts for gene i =
1, . . . ,m in sample j = 1, . . . , n. The scaling normalization
methods will derive a sample-specific normalization fac-
tor, denotedNj, while non-scaling methods will replace Yij
with the normalized ˜Yij.
Total count derives the normalization factor Nj as the
sum of all gene counts in a sample j [17, 18, 27], i.e.
Nj =
m
∑
i=1
Yij.
Total count thus adjust the abundance of each gene based
on the total number of DNA fragments that are binned
in the sample. Total count was implemented in R (version
3.2.1) [28] using the ’colSums’ function.
Median calculates the the normalization factor Nj as the
median of genes counts that are non-zero in at least one
sample, i.e.
Nj = mediani∈G∗ Yij, G
∗ =
⎧
⎨
⎩
i :
n
∑
j=1
Yij > 0
⎫
⎬
⎭
.
Median normalization provides a robust alternative to
total counts that is less influenced by most highly abun-
dant genes. Median normalization was performed using
the edgeR Bioconductor package (version 3.10.5) [29].
Upper quartile estimates the normalization factor Nj
as the sample upper quartile (75th percentile) of genes
counts that are non-zero in at least one sample [19], i.e.
Nj = upper quartile
i∈G∗
Yij, G∗ =
⎧
⎨
⎩
i :
n
∑
j=1
Yij > 0
⎫
⎬
⎭
.
In contrast to median, the upper quartiles of the gene
abundance distribution are used to calculate the scaling
factors which aims to further increase the robustness.
Upper quartile normalization was done using the edgeR
Bioconductor package (version 3.10.5) [29].
TMM calculates the normalization factor Nj using a
robust statistics based on the assumption that most genes
are not differentially abundant and should, in average, be
equal between the samples [21]. First, a sample r is chosen
as reference. For each sample j, genes are filtered based
on their mean abundance and fold-change between the
sample and the reference. An an adjustment f (r)j is then
calculated as the mean of the remaining log fold-changes
Table 1 Data-driven methods for normalization of shotgun metagenomic data included in this study
Method Description Availability
Total counts Calculates scaling factors based on the total gene
abundances
-
Median Calculates scaling factors based on the median gene
abundance
edgeR package in Bioconductor
Upper quartile [19] Calculates scaling factors based on the upper quartile
of the gene abundances
edgeR package in Bioconductor
Trimmed mean ofM-values (TMM) [21] Calculates scaling factors based on robust analysis of
the difference in relative abundance between sam-
ples.
edgeR package in Bioconductor
Relative Log Expression (RLE) [30] Calculates scaling factors using the ratio between
gene abundances and their geometric mean
DESeq package in Bioconductor
Cumulative sum scaling (CSS) [20] Calculates scaling factors as the cumulative sum of
gene abundances up to a data-derived threshold
metagenomeSeq package in Bioconductor
Reversed cumulative sum scaling (RCSS) Calculates scaling factors as the cumulative sum of
high abundant genes
-
Quantile-quantile [19] Transforms each sample to follow a data-derived ref-
erence distribution
-
Rarefying [55] Randomly removes gene fragments until the
sequencing depth is equal in all samples
phyloseq package in Bioconductor
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weighted by the inverse of the variance. The normalization
factor is then given by
Nj = f (r)j
m
∑
i=1
Yij.
TMM normalization was performed using the edgeR
Bioconductor package (version 3.10.5), which, by
default, trims 30% of log fold-change and 5% of mean
abundance [29].
RLE assumes most genes are non-DAGs and uses the
relative gene abundances to calculate the normalization
factor [22]. First, a reference is created for each gene i by
taking the geometric mean its abundances across all sam-
ples. The normalization factor Nj is then calculated as the
median of all ratios between gene counts in sample j and
the reference, i.e.
Nj = mediani
Yij
(
∏n
j′=1 Yij′
)1/n .
Normalization using RLE was done using the DESeq2
Bioconductor package (version 1.14.1) [30].
CSS is based on the assumption that the count distri-
butions in each sample are equivalent for low abundant
genes up to a certain threshold qlˆj , which is calculated
from the data [20]. First, the median of each lth quan-
tile across all samples is calculated. The threshold qlˆj is set
as the largest quantile where the difference between the
sample-specific quantiles is sufficiently small (measured
based on the distance to the median quantile). Note that
the threshold is set to be at least the 50th percentile. The
normalization factor for sample j is then computed as the
sum over the genes counts up to the threshold qlˆj , i.e.
Nj =
∑
i:Yij≤qlˆj
Yij.
CSS normalization was done using metagenomeSeq Bio-
conductor package (version 1.10.0) [20].
Reversed cumulative sum scaling (RCSS) is a variant of
CSS that utilize the observation that high-abundant genes
in shotgun metagenomic data have, in general, a lower
coefficient of variation [11]. RCSS therefore calculates the
normalization factor Nj as the sum of all genes with an
abundance larger than the median. The normalization
factor is thus given by,
Nj =
∑
i:Yij≥0.5
Yij.
RCSS was implemented in R (version 3.2.1) [28] using the
‘colQuantiles’ function from ‘matrixStats’ package (ver-
sion 0.51.0) and ’sum’ over a logical vector.
Quantile-quantile normalizes the data by transforming
each sample to follow a reference distribution [19]. The
reference distribution is calculated by taking the median
of all quantiles across the samples, i.e.
q¯l = medianj∈S q
l
j ,
where qlj is the lth quantile in the jth sample. The counts
Yij are then replaced by ˜Yij such that qlj = q¯l. If two
genes have same number of counts, i.e. Yaj = Ybj for
any a, b, such that a = b, the choice of which gene
receives which quantile is made randomly. We imple-
mented quantile-quantile in R (version 3.2.1) [28] adapted
from the algorithm presented in [24]. In order to preserve
the discrete structure of the data, the median over the
quantiles was calculated as outlined above and if the num-
ber of samples were even, one of the two middle values
was randomly selected.
Rarefying is a normalization method that discards frag-
ments from each sample until a predefined number of
fragments is the same for all samples [13, 23]. For each
sample, fragments are sampled without replacement. The
fragments that are not selected in this process are dis-
carded. In this study, the predefined number of fragments
was set to the lowest sample size among all included in the
dataset.
Identification of differentially abundant genes
The number of counts Yij in gene i and sample j was
modeled using a over-dispersed Poisson generalized linear
model (OGLM) [31, 32], i.e.
log
(
E
[
Yij|xj
]) = αi + βixj + log
(
Nj
)
,
where, αi is the log of the baseline counts expected for a
gene i, βi is the effect parameter that describes the relative
abundance of gene i between the two conditions, and xj is
an indicator function, such that xj = 1 if sample j belongs
to condition 1 and 0, otherwise. The counts Yij is assumed
to follow a Poisson distribution with a gene-specific scal-
ing of the variance (i.e. the so called quasi-Poisson model).
Furthermore, Nj was set to the factor corresponding to
the method used to normalize the data. For method
that does not use a normalization factor (rarefying and
quantile-quantile normalization), Nj was set to 1. The
model parameters αi and βi were estimated using maxi-
mum likelihood. Then, a gene is classified as a DAG using
an F-test, which decides whether the model with an effect
parameter is a better fit than the model without. FDR
was estimated using the Benjamini-Hochberg algorithm
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[33]. The OGLM was chosen for identification of DAGs
since it incorporates gene-specific between-sample vari-
ability and has previously been shown to have a high and
robust performance for many forms of shotgun metage-
nomic data. For a comparison between statistical methods
for identification of DAGs we refer the reader to [32].
Datasets
The normalization methods had their performance eval-
uated in three different publicly available metagenomic
datasets, here denoted Human gut I, Human gut II and
Marine. Human gut I contained 74 samples of sequenced
DNA from gut microbiome of control patients in a type-
2 diabetes study [5]. The choice of only using the controls
was done to exclude potentially large effects that may be
present between the healthy and sick individuals in this
study. The DNA was obtained from fecal samples, and it
was sequenced using Illumina sequencing to an average of
3.2·107 high quality reads per sample. Reads were mapped
to a common gene catalog and quantified. The gene cat-
alog was in turn mapped to eggNOG database v3.0 [34].
Human gut II contains 110 samples of sequenced DNA
from microbiomes in the human gut of healthy individu-
als in North and South America [35]. DNAwas sequenced
using massively parallel sequencing (454 sequencing) with
an average of 1.6 · 105 reads per sample. The reads were
downloaded from MG-RAST database [36], and trans-
lated into all six reading frames, which were in turn
mapped to eggNOG database v4.5 [37] using HMMER
[38]. Mapped reads with e-value of max 10−5 were kept.
The Marine dataset contains a set of samples from TARA
ocean project, a large oceanic metagenome study with a
total of 243 samples collected in 68 different locations
across the globe [6]. DNA was sequenced using Illumina
sequencing resulting in an average of 3.2 · 108 reads per
sample. Reads were mapped to an oceanic gene catalog
using MOCAT v1.2 [39] using the eggNOG database v3.0.
The count data was received directly from the project
authors. We selected the largest homogeneous experi-
mental condition consisting of 45 metagenomes extracted
from surface aquatic ocean samples using a filter sizes
between .22 to 3 μm. For all datasets, genes with more
than 75% zeros or mean abundance less than three were
excluded from the analysis, resulting in 3573, 2345 and
4372 genes for Human gut I, Human gut II and Marine,
respectively. The count data used in this study is available
at [40].
Resampling of data
The normalization methods were evaluated on artificial
data created by randomly sampling metagenomes with-
out replacement from each of the comprehensive datasets.
The artificial data was divided in two groups, represent-
ing two experimental conditions, each consisting of m
samples. Differentially abundant genes were introduced
by random selection of genes that had their number of
observed DNA fragments in one of the groups downsam-
pled. Thus, for gene i and sample j, the counts Yij were
replaced with a number generated by sampling from a
binomial distribution, such that
Yˆij|Yij ∼ Binomial(Yij, q),
where q is the effect size describing the average fold-
change in abundance. In the evaluation, the number of
samples in the groups as well as the total number of DAGs,
the distribution of DAGs between the groups and the
effect size q were varied.
Performance measures
The performance of the normalization methods was eval-
uated based on the TPR, which represents the ability to
correctly identify the DAGs, and on the FPR, which rep-
resents the amount of non-DAGs that were incorrectly
identified as DAGs. Given a ranking list of genes sorted
based on their p-values calculated by the statistical analy-
sis described above, the TPR and FPR at position k were
calculated as
TPR(k) = TP(k)#{DAGs} and FPR(k) =
FP(k)
#{non-DAGs} ,
where TP(k) is the number of true positive above posi-
tion k, FP(k) is the number of false positives above posi-
tion k and #{DAGs} and #{non-DAGs} were the total
number of DAGs and non-DAGs in the dataset, respec-
tively. The true FDR (tFDR) at position k was calculated as
tFDR(k) = FP(k)TP(k) + FP(k) .
while the estimated FDR (eFDR) was given by the
Benjamini-Hochberg algorithm [33]. All performance
measures were calculated based on 100 resampled
datasets. The cut-off position k was chosen as follows: for
the TPR analysis k corresponds to the position where FPR
is 0.01, for the FPR analysis k corresponds to the position
where TPR is 0.50, and for tFDR analysis k is the position
where eFDR is 0.05.
Results
In this study, we compared the performance of nine
normalization methods for shotgun metagenomic gene
abundance data. The comparison was made on artifi-
cial data consisting of two groups, created by individual
resampling without replacement of three comprehensive
metagenomic datasets. In the resampling, DAGs were
introduced by randomly selecting genes to have their
number of counts in one of the two groups downsam-
pled. Each artificial dataset was normalized using the nine
different methods and the ability to correctly identify
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the DAGs was assessed. This set-up was used to investi-
gate how the performance of the normalization methods
changed under different characteristics of the data such
as group size, proportion of DAGs and their distribution
between the two groups.
First, all methods were evaluated with the DAGs sym-
metrically distributed between the two groups. Here, 10%
of the genes were selected to be DAGs with an average
fold-change of 3 and the group size was set to 10 + 10.
The Human gut I and Marine datasets showed the over-
all highest performance for detecting DAGs (average TPR
of all methods 0.63 and 0.67 respectively), while Human
gut II, which had a substantially lower sequencing depth,
had an average TPR of 0.61 (at a fixed FPR of 0.01, Fig. 1a
and Table 2). Within each datasets, the normalization
methods showed a similar performance. One exception
was quantile-quantile that had a higher performance in
Human gut I, with median TPR of 0.69 compared to
the other methods that had a TPR around 0.62. Another
exception was normalization using rarefying, which had a
lower performance in Human gut II with a median TPR of
0.49 compared to the other methods with TPR of at least
0.62. In addition, CSS and median had a slighter higher
performance in the Marine datasets, with TPR of 0.69 and
0.68, respectively, while other methods had a TPR around
0.66.
When effects instead were added in an unbalanced way,
i.e. 10% DAGs added to the same group (Fig. 1b and
Table 2), the performance of all methods decreased sub-
stantially, reducing the TPR, in average, with 9.0 p.p. (for
an extended discussion on unbalanced DAGs in metage-
nomics see [41]). In this setting, upper quartile showed a
TPR of 0.42 for the Marine dataset, which was, compared
to its TPR of 0.66 in the balanced case, a reduction of 24
p.p.. The TPR of quantile-quantile normalization was also
reduced to a TPR of 0.54 and 0.46 in the Human gut II and
Marine datasets respectively. Reduced performance was
also observed for CSS and median in at least one dataset
(Table 2). The decrease in performance was, on the other
hand, not as large for TMM and RLE which had a TPR
between 0.55 and 0.61 for the three dataset correspond-
ing to an average reduction in TPR of 4.5 and 5.6 p.p.,
respectively.
Decreasing the group size to 3+ 3 resulted, as expected,
in a reduced TPR (Fig. 2a and Table 3). For this group size,
CSS and median had, compared to other methods, a par-
ticularly low performance. For example, in the balanced
case in Human gut I, the TPR for these methods were 0.20
and 0.22 respectively, compared to othermethods that had
a TPR between 0.28 or 0.29. A similar trend was observed
for quantile-quantile, which for larger group sizes was
one of the highest performing methods. The trend of a
substantially reduced TPR for CSS, median and quantile-
quantile with reduced group size was further accentuated
in the unbalanced case (Fig. 2b and Table 3). As previ-
ously, TMM and RLE had the overall highest TPR at low
group sizes. Their performance was especially high in the
Marine datasets, where the TPR was 0.36 for both TMM
and RLE, respectively (Fig. 2b and Table 3).
Next, we compared the results of the normalization
methods with respect to the underlying gene abundance
distributions. As expected, all scaling methods estimated
scaling factors that were highly correlated with the aver-
age gene abundance (Additional file 1: Figure S1). Several
of the methods estimated scaling factors that were highly
correlated. The correlations were especially high between
total counts and upper quartile (0.99), total counts and
RCSS (0.99), upper quartile and RCSS (0.97) as well as
TMM and RLE (0.952) (Additional file 2: Figure S2) sug-
gesting that these methods are likely to generate similar
normalization results. In contrast, the lowest correlations
were found between CSS and RCSS (0.53), total counts
and CSS (0.63) and median and RCSS (0.65). Further-
more, improper normalization is known to introduce false
correlation between genes and to investigate this, we cal-
culated the average pair-wise gene correlation before and
after normalization (Additional file 3: Figure S3). Most
normalization methods introduced a small increase in the
gene-gene correlation. The increase was highest for upper
quartile (0.035), total counts (0.027) and RCSS (0.027).
However, no increase could be found for quantile-quantile
and median.
In order to further investigate the impact of unbalanced
distribution of DAGs between groups on the normaliza-
tion performance, we fixed the group size to 10 + 10
and the fold-change to 3, and compared all the methods
under four different cases, each representing an increasing
asymmetry of the distribution of DAGs: balanced effect
(10% DAGs equally distributed over the two groups),
lightly-unbalanced effects (10% DAGs, 75% in one group,
25% in the other group), unbalanced effects (10% DAGs,
100% in one group) and heavily-unbalanced effects (20%
DAGs, 100% in one group). First, the impact of unbal-
anced DAGs on the methods performance was measured
in terms of TPR at a fixed FPR of 0.01 (Fig. 3a and Addi-
tional file 4: Table S1). For all methods, the TPR was
reduced with a more unbalanced effect added, and all
methods had their lowest TPR at the heavily-unbalanced
case. The reduction in TPR was lowest for TMM and RLE.
For instance, in the Human gut I, TMM had a TPR of
0.62, 0.61, 0.58 and 0.48, for balanced, lightly-unbalanced,
unbalanced and heavily-unbalanced cases respectively.
The corresponding number for RLE was 0.63, 0.60, 0.55
and 0.42, while quantile-quantile showed 0.69, 0.65, 0.56
and 0.34, upper quartile 0.61, 0.57, 0.49 and 0.28 and
median 0.62, 0.58, 0.50 and 0.33.
Next, we investigated the FPR at a fixed TPR of 0.50
(Fig. 3b and Additional file 5: Table S2). The trend was
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Fig. 1 True positive rate analysis for group size 10 + 10. True positive rate at a fixed false positive rate of 0.01 (y-axis) for nine normalization methods
and three metagenomic datasets (x-axis). The results were based on resampled data consisting of two groups with 10 samples in each, 10% DAGs
with an average fold-change of 3. The DAGs were added in (a) equal proportion between the groups (‘balanced’) and in (b) in only one of the
groups (’unbalanced’). The following methods are included in the figure: trimmed mean ofM-values (TMM), relative log expression (RLE), cumulative
sum scaling (CSS), reversed cumulative sum scaling (RCSS), quantile-quantile (Quant), upper quartile (UQ), median (Med), total count (TC) and
rarefying (Rare)
Table 2 True positive rate analysis for group size 10 + 10
Method
Human gut I Human gut II Marine
B U B U B U
TMM 0.62 0.58 0.63 0.59 0.66 0.61
RLE 0.63 0.55 0.62 0.60 0.66 0.59
CSS 0.61 0.53 0.65 0.55 0.69 0.61
RCSS 0.61 0.56 0.62 0.59 0.65 0.50
Quantile-quantile 0.69 0.56 0.64 0.54 0.67 0.46
Upper quartile 0.61 0.49 0.63 0.56 0.66 0.42
Median 0.62 0.50 0.64 0.52 0.68 0.59
Total count 0.61 0.54 0.63 0.57 0.65 0.49
Rarefying 0.63 0.57 0.49 0.44 0.66 0.50
True positive rate at a fixed false positive rate of 0.01 for nine normalization methods and three metagenomic datasets using a group size of 10 + 10 for 10% DAGs with an
average fold-change of 3.
B: balanced, 50% of effects added to each group.
U: unbalanced, 100% effects added to one group only
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Fig. 2 True positive rate analysis for group size 3 + 3. True positive rate at a fixed false positive rate of 0.01 (y-axis) for nine normalization methods
and three metagenomic datasets (x-axis). The results were based on resampled data consisting of two groups with 3 samples in each, 10% DAGs
with an average fold-change of 3. The DAGs were added in (a) equal proportion between the groups (‘balanced’) and in (b) only one of the groups
(‘unbalanced’). The following methods are included in the figure: trimmed mean of M-values (TMM), relative log expression (RLE), cumulative sum
scaling (CSS), reversed cumulative sum scaling (RCSS), quantile-quantile (Quant), upper quartile (UQ), median (Med), total count (TC) and rarefying
(Rare)
Table 3 True positive rate analysis for group size 3 + 3
Methods
Human gut I Human gut II Marine
B U B U B U
TMM 0.28 0.25 0.21 0.18 0.40 0.36
RLE 0.28 0.25 0.20 0.17 0.40 0.36
CSS 0.20 0.15 0.18 0.12 0.32 0.28
RCSS 0.28 0.27 0.21 0.18 0.39 0.33
Quantile-quantile 0.28 0.24 0.16 0.13 0.37 0.29
Upper quartile 0.29 0.24 0.21 0.18 0.40 0.29
Median 0.22 0.17 0.18 0.12 0.35 0.28
Total count 0.29 0.26 0.21 0.17 0.39 0.33
Rarefying 0.29 0.26 0.13 0.10 0.40 0.33
True positive rate at a fixed false positive rate of 0.01 for nine normalization methods and three metagenomic datasets using a group size of 3 + 3 for 10% DAGs with an
average fold-change of 3.
B: balanced, 50% of effects added to each group.
U: unbalanced, 100% effects added to one group only
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Fig. 3 True and false positive rates for increasing unbalanced effects. (a) True positive rate at a fixed false positive rate of 0.01 (y-axis) and (b) false
positive rate at a fix true positive rate of 0.50 (y-axis) for different distributions of effects between groups: balanced (’B’) with 10% of effects divided
equally between the two groups, lightly-unbalanced (‘LU’) with effects added 75%-25% in each group, unbalanced (’U’) with all effects added to only
one group, and heavily-unbalanced (‘HU’) with 20% of effects added to only one group (x-axis). The results were based on resampled data consisting
of two groups with 10 samples in each and an average fold-change of 3. Three metagenomic datasets were used Human gut I, Human gut II and
Marine. The following methods are included in the figure: trimmed mean ofM-values (TMM), relative log expression (RLE), cumulative sum scaling
(CSS), reversed cumulative sum scaling (RCSS), quantile-quantile (Quant), upper quartile (UQ), median (Med), total count (TC) and rarefying (Rare)
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monotone with a increasing number of false positives for
more unbalanced effects. Most methods had a low num-
ber of FPR for the balanced and lightly-unbalanced cases.
Exception was rarefying, which for Human gut II, had an
FPR of 0.011 already in the balanced case, while the other
methods had an FPR of nomore than 0.0022. In the unbal-
anced case, all methods showed an increased FPR. The
increase was especially large for quantile-quantile (FPR
of 0.050 in Marine), upper quartile (FPR of 0.020 in the
Marine dataset) and rarefying (FPR of 0.010 in Human
gut II). For the heavily-unbalanced case, the FPR was fur-
ther increased. The levels were especially high for RCSS,
quantile-quantile, upper quartile, median, total count and
rarefying (Additional file 5: Table S2). It should be noted
that for the Marine, upper quartile reached an FPR above
0.20, indicating that the number of false positives sur-
passed the number of added DAGs (Fig. 3b). TMM, RLE
and CSS, on the other hand, presented an overall sta-
ble performance. For the heavily-unbalanced base, TMM
had an FPR between 0.0036 to 0.016, RLE between 0.012
and 0.028 and CSS between 0.011 and 0.041 for all three
datasets. Note that, the performance of all methods, both
in terms of increased TPR and decreased FPR, was further
pronounced when the fold-change was increased to 5, i.e.
p = 1/5 (Additional file 4: Table S1 and Additional file 5:
Table S2).
In addition, we examined the bias of the effect size esti-
mated by the OGLM under balanced, lightly-unbalanced,
unbalanced and heavily-unbalanced cases (Additional
file 6: Figure S4). For the balanced case, all methods
resulted in estimated effect sizes close to the true fold-
change of 3. However, when the effects became unbal-
anced several methods underestimated the effect size.
This underestimation was especially large for CSS,
upper-quartile and median. In particular, in the heavily-
unbalanced case, median underestimated the effect size
with more than 20%. In contrast, the estimates were less
unbiased for TMM, RLE, RCSS, total counts and rarefying.
False positives are often a result of a skewed non-
uniform p-value distribution under the null hypothe-
sis. We therefore examined the p-value distribution of
the non-DAGs for the different normalization methods
(Fig. 4). In the balanced case where the DAGs were sym-
metrically distributed over the groups, several methods,
in particular TMM, quantile-quantile and total count,
showed small but consistent trends towards too optimistic
p-values, i.e. p-values that are smaller than expected com-
pared to the uniform distribution. However, when the
effect was changed to be heavily-unbalanced, the bias
towards too optimistic p-values increased substantially for
all methods. Methods producing the most biased p-value
distributions were quantile-quantile and upper quartile.
The bias was still present but not as serious for TMM,
RLE, RCSS and CSS.
Finally, the ability to control the FDR was evaluated. For
each normalization method, the true FDR was calculated
at a fixed estimated FDR of 0.05 (Fig. 5 and Additional
file 7: Tables S3). For the balanced case, all methods were
conservative and showed a true FDR that was smaller
than the estimated FDR. This changed, however, when the
DAGs were added in an unbalanced way. For the Marine
dataset in the lightly-unbalanced case, where 75% of the
DAGs were added to one group, quantile-quantile and
upper quartile showed a true FDR of 0.061 and 0.096,
respectively, which was higher than the estimated 0.05. In
the unbalanced case, five out of the nine methods were
not able to control the FDR in at least one dataset. For
instance, upper quartile demonstrated an especially large
true FDR of 0.53 in the Marine. For heavily-unbalanced
cases, none of the methods were able to control the FDR
in any of the datasets. Still, TMM, RLE and CSS had a less
biased true FDR than the other methods. In particular, the
true FDR of TMM was close to 0.10 in all three datasets.
On the other hand, RCSS, quantile-quantile, upper quar-
tile, total count and rarefying resulted in unacceptably
high FDRs (close to or above 50%) in at least one dataset.
Discussion
In this paper, we compared nine methods for the nor-
malization of metagenomic gene abundance data. The
ultimate aim of the normalization step is the removal of
unwanted systematic effects and thereby the reduction
of the between-sample variability. This can significantly
increase the ability to correctly identify DAGs, and to
reduce the number of false positives. In this study, the
normalization methods were therefore evaluated based
on their statistical performance when identifying DAGs
between experimental conditions. The performance was
measured in terms of TPR, FPR, skewness of the p-value
distributions and the ability to control the FDR. The com-
parison was done under realistic settings by utilizing arti-
ficial datasets created by individual resampling of three
comprehensive metagenomic studies, representing both
different forms of microbial communities and sequencing
techniques. Our results showed that most of the included
methods could satisfactory normalize metagenomic gene
abundance data when the DAGs were equally distributed
between the groups. However, when the distribution of
DAGs become more unbalanced the performance was
substantially reduced. In particular, many methods suf-
fered from decreased TPRs, increased number of false
positives and the inability to control the FDR. The size of
the groups had also a major impact on the relative nor-
malization results with several methods underperforming
when only few samples were present.
TMM and RLE had the overall best performance, both
in terms of TPR and FPR, for all three investigated
datasets. Their performance, in relation to other methods,
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Fig. 4 Quantile-quantile plots for p-values of non-DAGs. Data quantiles for the Human gut I dataset (y-axis) were plotted against the theoretical
quantiles of the uniform distribution (x-axis) for nine normalization methods. The results were based on resampled data consisting of two groups
with 10 samples in each, an average fold-change of 3, for balanced (‘B’) case where 10% effects were equally distributed in the two groups and
heavily-unbalanced (‘HU’) case where 20% effects were added in only one group. Each dashed line is one of the 100 iterations. Lines deviating from
the diagonal indicates biased p-values. The following methods are included in the figure: trimmed mean of M-values (TMM), relative log expression
(RLE), cumulative sum scaling (CSS), reversed cumulative sum scaling (RCSS), quantile-quantile (Quant), upper quartile (UQ), median (Med), total
count (TC) and rarefying (Rare)
was especially high in the unbalanced case. In fact, TMM
and RLE had an FPR less than 0.05 in all evaluations and
datasets. TMM had, in most cases, slightly higher TPR
and lower FPR than RLE, making it the highest perform-
ing method in this study. In addition, both TMM and RLE
showed less biased estimates of the effect size and their
estimated scaling factors showed high correlations. Larger
effects on the gene abundances will significantly alter the
count distributions which may result in incorrectly esti-
mated scaling factors. TMM and RLE try to circumvent
this problem by estimating the scaling factor from the
relative difference of the gene abundance between the
samples. For TMM, this procedure is done by compari-
son of samples against a reference sample and estimating
scaling factors that minimize the pairwise differences.
RLE estimates instead a reference by calculate the average
gene abundance using a geometric mean. Scaling factors
that minimize the difference between the each sample and
reference are then calculated. By using robust statistics,
both methods exclude genes that have a high relative dif-
ference, i.e. genes that are likely to be differentially abun-
dant, which increase the accuracy of the estimated scaling
factor. In contrast, the other scaling method included in
this study (CSS, RCSS, upper quartile, median, and total
count) estimates the scaling factors directly from the abso-
lute gene abundances. This makes it harder to exclude
differentially abundant genes and as a consequence, the
scaling factors may become biased, especially when the
effects are asymmetric. The high performance of TMM
and RLE observed in this study is in line with previous
evaluations on other forms of count data. For example,
McMurdie et al. [13] showed that RLE had a high per-
formance when normalizing data from operational taxo-
nomic units (OTUs) generated by amplicon sequencing.
Also, Dillies et al. [26] showed that TMM and RLE were
the most efficient methods for reducing the between-
sample variability in count data from RNA sequencing.
Our results showed that this also holds true for shotgun
metagenomic data and demonstrated that TMM and RLE
increase the ability to identify DAGs and reduce the false
positives. In addition to TMM and RLE, CSS showed a
high overall performance for larger group sizes. CSS was
particularly good at controlling the FDR, even when the
effect was highly unbalanced. Even though CSS does not
utilize the relative gene abundances, it tries to optimize
what genes to include when calculating the scaling factor.
This is done by summing low-abundant genes up to a cut-
off that is adaptively selected from the data to minimize
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Fig. 5 True false discovery rate at an estimated false discovery rate of 0.05 (y-axis) for different distribution of effects between groups (x-axis):
balanced (‘B’) with 10% of effects divided equally between the two groups, lightly-unbalanced (‘LU’) with effects added 75–25% in each group,
unbalanced (‘U’) with all effects added to only one group, and heavily-unbalanced (’HU’) with 20% of effects added to only one group. The results
were based on resampled data consisting of two groups with 10 samples in each, and an average fold-change of 3. P-values where adjusted using
Benjamini-Hochberg correction. Three metagenomic datasets were used Human gut I, Human gut II and Marine. The following methods are
included in the figure trimmed mean ofM-values (TMM), relative log expression (RLE), cumulative sum scaling (CSS), reversed cumulative sum
scaling (RCSS), quantile-quantile (Quant), upper quartile (UQ), median (Med), total count (TC) and rarefying (Rare)
the variability. It should, however, be noted that CSS had
among the worst performance for the low group size
(Fig. 2), strongly suggesting that this method only should
be applied to datasets with sufficiently many samples.
On the other end of the scale, normalization using
quantile-quantile, median and upper quartile, as well as
rarefying the data, had the overall lowest performance.
The difference in TPR, compared to highest performing
methods, was especially large in the heavily-unbalanced
cases where DAGs were exclusively present in one of the
samples. Taking the Marine dataset as an example, the
TPR for these methods were 20 p.p. lower than TMM
and RLE, which had the highest overall performance. All
these methods also resulted in high FPRs that reached,
in many cases, unacceptable levels. Among these low-
performing methods, upper quartile and rarefying also
resulted in inflated gene-gene correlation. Thus, quantile-
quantile, median, upper quartile and rarefying are not
recommended for normalization of metagenomic gene
abundance data. Interestingly, the straight-forward total
count method, which uses the total abundance of all genes
in a sample as the basis for the normalization, had, over-
all, similar or higher performance than median and upper
quartile. One argument for not using total count is that
the sum of all gene abundances can be heavily domi-
nated by the genes that are most commonly present in the
microbial community. Instead, median and upper quar-
tile should represent robust alternatives that avoid the
most commonly present genes by replacing the sum with
the 50th or 75th percentile of the gene count distribu-
tion as scaling factor. We did not, however, observe any
tendencies that median or upper quartile had an over-
all higher performance than total count. On the contrary,
the scaling factors estimated from total count and upper
quartile had a very high correlation, which has also been
shown in previous studies [42], suggesting that they pro-
duce a similar result. The performance of these methods
were indeed similar with a small advantage for total count,
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which had an overall higher TPR and a lower FPR. It
should, however, be pointed out that upper quartile has
been developed specifically for transcriptomics, and has
previously shown, using spike-in controls, to have a rea-
sonable performance for normalization of RNA-seq [26].
Our results may therefore, at least partially, reflect differ-
ences in data structure between shotgun metagenomics
and transcriptomics. It should, finally, be noted that the
RAIDA R-package contains a normalization method for
metagenomic gene abundances that has showed promis-
ing results for unbalanced effects [41]. However, this
method is tightly connected with the specific log-normal
statistical model implemented in the RAIDA package and
since it is not generally applicable, there was no straight-
forward way to include it in this comparison.
The p-values for non-DAGs should, in theory, follow
a uniform distribution. Our results showed that this
was not the case. In the situations where the DAGs
where distributed between the groups in a balanced way,
all methods generated p-value distributions that were
approximately uniform. However, when the DAGs were
only present in one of the groups, the p-value distribution
of the non-DAGs became skewed against low values.
Metagenomic gene abundances are measured relatively
to the sequencing depth and genes that are differentially
abundant will therefore, indirectly, also affect non-DAGs.
If a normalization method fails to compensate for this
’artificial’ effect, it may result in too low p-values for
non-DAGs and, in turn, in an excessive number of false
positives. Our results showed that quantile-quantile and
upper quartile normalization methods had the most
biased p-values, suggesting that this, at least partially, is
likely the cause for their high FPR. Furthermore, previous
studies have shown that statistical models for identifi-
cation of DAGs in shotgun metagenomics can result in
highly biased p-values if their underlying assumptions
are invalid [32]. In particular, gene count models that
does not incorporate gene-specific variability, such as
the popular Fisher’s exact test, can incorrectly interpret
high overdispersion as biological effects which may result
in large numbers of false positives [11, 43]. It should be
emphasized that in contrast to the biased p-values caused
by invalid model assumptions, the skewed p-value distri-
butions generated by improper normalization observed
in this study, can not be addressed by replacing the para-
metric model (the overdispersed Poisson model), with
e.g. a non-parametric method or a permutation-based
approach.
The FDR is used to control the error rate in multiple
testing of high-dimensional data [33]. Correct estimation
of the FDR is highly dependent on a uniform p-value
distribution for non-DAGs. Biased FDR estimation may
result in a large number of false positives genes, i.e.
non-DAGs incorrectly reported as significant. Our results
showed that all normalization methods achieved a cor-
rectly estimated FDR when the effects were balanced.
However, similarly to the p-values, the FDR became
biased when the DAGs were introduced in an unbal-
anced way. Already at the lightly-unbalanced case, where
effects were added to 10% of the genes distributed 75%-
25% between the groups, two methods (quantile-quantile,
upper quartile) were unable to control the FDR for at
least one dataset. At the unbalanced case (10% of the
genes set as DAGs, all in one group), six of the nine
methods resulted in considerably biased FDR estimates.
Only TMM, RLE and CSS were able to correctly con-
trol the FDR and only showed a moderate bias at the
heavily-unbalanced case (20% of the genes set as DAGs,
all in one group). Several of the other methods however
showed an unacceptable FDR bias. In particular, RCSS,
quantile-quantile, upper quartile and total count had a
true FDR close to 50% when the corresponding estimated
FDR was fixed to 5%. Our results thus show that many
normalization methods produce highly skewed p-value
distribution, which results in biased FDRs, as soon as
the DAGs becomes unbalanced between the groups. It
is worth to note that changing the approach for control-
ling the FDR to the more conservative Benjamini-Yekutieli
method or the Storey q-values method did not remove
the bias or resulted in a considerably reduced statistical
power (Additional file 8: Figure S5 and Additional file 9:
Figure S6, respectively). Controlling the number of false
positive genes is vital in high-throughput data analysis
[44, 45], since a high proportion of false positive can result
in incorrect interpretation of the results and, in worst
case, wrong biological conclusions. Using a normalization
method that can reliably analyze gene abundance from
shotgun metagenomics data without generating an unac-
ceptably high false positive rate is thus vital for statistically
sound results.
Rarefying normalizes count data by randomly removal
of DNA fragments until all samples have the same prede-
fined sequencing depth. Rarefying is commonly used in
metagenomics [46–48] and has been both argued for and
against in recent studies [13, 23]. In the present work, we
showed that rarefying had a relatively low performance for
normalization ofmetagenomic gene abundance data, both
in terms of TPR, FPR and the ability to control the FDR.
Since the ability to correctly identify DAGs increase with
increasing number of DNA fragments, discarding data, as
done by the rarefying method, has a negative effect on
the performance. The performance was particularly low
for the Human gut II dataset, where the TPR was low in
all tested cases (e.g. Figs. 1a and 3a). Human gut II had
the lowest sequencing depth of the datasets used in this
study, and the effect was therefore most visible here. How-
ever, even for the two other datasets, which hadmore than
200-fold larger number of DNA fragments, rarefying still
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was among the methods with the lowest performance. For
instance, in the Marine dataset (Fig. 5), rarefying resulted
in a highly biased FDR estimation for both the unbalanced
and the heavily-unbalanced cases. The low performance
of rarefying in the datasets with high sequencing depth
can, at least partially, be explained by the fact that genes
that are low-abundant in a community, are also in gen-
eral represented by few DNA fragments even in datasets
with high sequencing depth, and discarding reads will
have a particularly negative effect on these genes. Our
results are thus in line with [13], who has previously
demonstrated that rarefying has a low performance on
count data from OTUs generated by amplicon sequenc-
ing. It should, in this context, be pointed out that there
are situations where rarefying data may be necessary. This
includes, for example, the estimation of diversity indices
that are dependent on the sequencing depth and that have
no straight-forward to incorporate a normalization scal-
ing factor. However, for the identification of DAGs, the
use of rarefying as a method to correct for differences in
sequencing depth should be avoided.
The evaluation of normalization methods presented
in this study was based on artificial gene count data
generated by individual resampling three comprehensive
metagenomic datasets. DAGs were introduced into the
data by downsampling selected genes to simulate a lower
abundance within the community. Thus, our setup was
non-parametric and conserves important parts of the
complex variance structure present in real metagenomic
data. This includes, for example, the underlying discrete
count distributions, the between-gene correlation and the
sparsity of the data. In contrast, data used in previous
studies (e.g. [13, 23, 26]) were simulated from paramet-
ric distributions and thus represent highly idealized cases.
Even though our results are based on real metagenomic
data, there are still specific assumptions made that are
likely not to be true. The study is, for example, based
on three datasets, which is too few to cover the full
heterogeneity of the data generated within the field of
metagenomics. Also, the resampling to form the artifical
datasets was done independently which removes any cor-
relations that may exist between the metagenomic sam-
ples. The downsampling used to create DAGs was done
independently between the genes, disregarding correla-
tions between effects which has previously been observed
in microbial communities [49, 50]. Furthermore, some of
the analyzed cases, in particular when all effects were
added only to one experimental group, may be unrealistic
and not common for many forms of metagenomic exper-
iments. Nevertheless, unbalanced distribution of DAGs is
not uncommon in metagenomic data, and may, for exam-
ple, be a result of a strong selection pressures affecting
one of the experimental groups [51–53]. Also, the nature
of the effect is also often hard to predict a priori and
normalization methods that do not have an overall high
performance should therefore be avoided. The results
from the current study should, ideally, be complemented
with data that closer resemblance true metagenomic stud-
ies. However, a comprehensive reference dataset for shot-
gun metagenomics, similarly to SEQC in transcriptomics
[54], needs to be established before such an analysis can
be performed. Nevertheless, even if our data generation
approach did not reflect all the nuances of metagenomic
data and our evaluated cases did not represent all possi-
ble forms of biological effects, we argue that our approach
is more sound and provides considerably more realistic
results thanmethod comparisons based on simulated data
from parametric distributions.
Conclusion
In conclusion, our evaluation showed that the choice of
normalization method can greatly affect the quality of
the results in the analysis of gene abundances in shotgun
metagenomic data.When DAGs were asymmetrically dis-
tributed between experimental conditions, several well-
established normalization methods showed a decreased
TPR and an increased FPR. The high FPR resulted, for
many methods, in an unacceptably biased FDR which can
lead to a large number of false positives. The highest per-
forming normalization methods in our study were TMM
and RLE, and for larger group sizes CSS, which showed
a high TPR and low FPR. These methods were also the
best in controlling the FDR. Normalization is an essen-
tial step in the analysis of gene abundances in shotgun
metagenomics. Our results emphasize the importance of
selecting a sound and appropriate method for this task.
They also demonstrates that the use of inappropriate nor-
malization methods may obscure the biological interpre-
tation of data. Further research for improved data-driven
normalization of shotgun metagenomic data is therefore
warranted.
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Additional file 1: Figure S1. Histograms of Spearman correlations
between normalization factors and raw counts of non-differentially
abundant genes (non-DAGs). Spearman correlations were compute per
gene in the Human gut I, for group size 10+ 10, with 10% of effects divided
equally between the two group, and fold-change 3. Affected genes were
randomly selected in 100 iterations. The following methods are included in
the figure trimmed mean of M-values (TMM), relative log expression (RLE),
cumulative sum scaling (CSS), reversed cumulative sum scaling (RCSS),
upper quartile (UQ), median (Med) and total count (TC). (PDF 76 kb)
Additional file 2: Figure S2. Scatterplot of normalization factors for each
pair of scaling methods. Normalization factors estimated per sample in the
Human gut I, for group size 10 + 10, with 10% of effects divided equally
between the two group, and fold-change 3. Affected genes were randomly
selected in 100 iterations. The number on the top-left of each plot indicates
the Spearman correlation for the normalization factors presented in the
plot. The following methods are included in the figure trimmed mean of
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M-values (TMM), relative log expression (RLE), cumulative sum scaling
(CSS), reversed cumulative sum scaling (RCSS), upper quartile (UQ), median
(Med) and total count (TC). (PDF 316 kb)
Additional file 3: Figure S3.Mean Spearman correlation between raw
and normalized counts. Spearman correlations were compute per gene
before and after normalization in the Human gut I, for group size 10 + 10,
with 10% of effects divided equally between the two group, and fold-
change 3. Affected genes were randomly selected in 100 iterations. The
following methods are included in the figure trimmed mean of M-values
(TMM), relative log expression (RLE), cumulative sum scaling (CSS), reversed
cumulative sum scaling (RCSS), quantile-quantile (Quant), upper quartile
(UQ), median (Med), total count (TC) and rarefying (Rare). (PDF 8 kb)
Additional file 4: Table S1. True positive rate at a fixed false positive rate
of 0.01 for a group size of 10 + 10. (PDF 16 kb)
Additional file 5: Table S2. False positive rate at a fix true positive rate of
0.50 for a group size of 10 + 10. (PDF 16 kb)
Additional file 6: Figure S4. Effect size analysis of DAGs. Estimated effect
size of differentially abundant genes (DAGs) (y-axis) for different distribution
of effects between groups (x-axis): balanced (‘B’) with 10% of effects
divided equally between the two groups, lightly-unbalanced (’LU’) with
effects added 75%-25% in each group, unbalanced (‘U’) with all effects
added to only one group, and heavily-unbalanced (’HU’) with 20% of
effects added to only one group (x-axis). The results were based on
resampled data consisting of two groups with 10 samples in each, and an
average fold-change of 3. Three metagenomic datasets were used Human
gut I, Human gut II and Marine. The following methods are included in the
figure trimmed mean ofM-values (TMM), relative log expression (RLE),
cumulative sum scaling (CSS), reversed cumulative sum scaling (RCSS),
quantile-quantile (Quant), upper quartile (UQ), median (Med), total count
(TC) and rarefying (Rare). (PDF 436 kb)
Additional file 7: Table S3. True false discovery rate at an estimated false
discovery rate of 0.05 for a group size of 10 + 10. (PDF 16 kb)
Additional file 8: Figure S5. True false discovery rate for p-values
adjusted using Benjamini-Yekutieli method at an estimated false discovery
rate of 0.05 (y-axis) for different distribution of effects between groups
(x-axis): balanced (‘B’) with 10% of effects divided equally between the two
groups, lightly-unbalanced (’LU’) with effects added 75%-25% in each
group, unbalanced (‘U’) with all effects added to only one group, and
heavily-unbalanced (’HU’) with 20% of effects added to only one group.
The results were based on resampled data consisting of two groups with
10 samples in each, and an average fold-change of 3. Three metagenomic
datasets were used Human gut I, Human gut II and Marine. The following
methods are included in the figure trimmed mean ofM-values (TMM),
relative log expression (RLE), cumulative sum scaling (CSS), reversed
cumulative sum scaling (RCSS), quantile-quantile (Quant), upper quartile
(UQ), median (Med), total count (TC) and rarefying (Rare). (PDF 40 kb)
Additional file 9: Figure S6. True false discovery rate for p-values
adjusted using Storey q-values method at an estimated false discovery rate
of 0.05 (y-axis) for different distribution of effects between groups (x-axis):
balanced (‘B’) with 10% of effects divided equally between the two groups,
lightly-unbalanced (‘LU’) with effects added 75–25% in each group,
unbalanced (‘U’) with all effects added to only one group, and heavily-
unbalanced (‘HU’) with 20% of effects added to only one group. The results
were based on resampled data consisting of two groups with 10 samples
in each, and an average fold-change of 3. Three metagenomic datasets
were used Human gut I, Human gut II and Marine. The following methods
are included in the figure trimmed mean of M-values (TMM), relative log
expression (RLE), cumulative sum scaling (CSS), reversed cumulative sum
scaling (RCSS), quantile-quantile (Quant), upper quartile (UQ), median
(Med), total count (TC) and rarefying (Rare). (PDF 132 kb)
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